OncLive® On Air

Non-Small Cell Lung Cancer

Clinical Trials

Triple Negative Breast Cancer

Breast Cancer

Immunotherapy

Small Cell Lung Cancer

FDA Approval

Chronic Lymphocytic Leukemia

Multiple Myeloma

Antibody Drug Conjugates

Chemotherapy

Oncology

Metastatic Colorectal Cancer

Prostate Cancer

Bladder Cancer

Colorectal Cancer

BTK Inhibitors

Surgery

Pembrolizumab

Biomarker Testing

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

32 ratings

Publishes	Daily	Episodes	500	Founded	8 years ago
Number of Listeners		Categories	ScienceHealth & Fitness

Listen to this Podcast

Guests Hosts Reviews Talking Points

Latest Episodes

S17 Ep28: In-House Molecular Testing in NSCLC Improves Turnaround Time, Tissue Stewardship, and Multidisciplinary Coordination: Featuring Anthony Chi, MD; Monica Peravali, MD; and Archana Jadhav, MD

In today’s episode, we spoke with Anthony Chi, MD, a staff pathologist; Monica Peravali, MD, a medical oncologist; and Archana Jadhav, MD, a medical oncologist, all faculty at the Mid-Atlantic Permanente Medical Group in Maryland.

In our exclusive ... more

Yesterday • 30 min

S17 Ep27: Advances in Cervical Cancer: Prevention, Immunotherapy, and the Rise of Antibody-Drug Conjugates: With Ursula A. Matulonis, MD; and Meghan E. Shea, MD

From Discovery to Delivery: Charting Progress in Gynecologic Oncology, hosted by Ursula A. Matulonis, MD, brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Dr Matulonis i... more

27 May 2026 • 15 min

S17 Ep26: Emerging Targets, Second-Line Standards, and Molecular Subtyping Signal a New Era in SCLC Care: With Jacob Sands, MD

In today’s episode, we spoke with Jacob Sands, MD. Dr Sands is the associate chief of the Lowe Center for Thoracic Oncology, Oncology Medical Director of the International Patient Center, and physician at Dana-Farber Cancer Institute, as well as an a... more

26 May 2026 • 24 min

S17 Ep25: TKIs Continue to Move Forward and Expand Their Potential in CML: With Michael J. Mauro, MD

In today’s episode, we spoke with Michael J. Mauro, MD, an attending physician at Memorial Sloan Kettering Cancer Center in New York, New York.

In our exclusive interview, Dr Mauro discussed the vast assortment of TKIs available for the treatment of... more

23 May 2026 • 16 min

Key Facts

Accepts Guests

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc DocsSam and Karine

Oncology Brothers: Practice-Changing Cancer DiscussionsOncology Brothers

Oncology Today with Dr Neil LoveDr. Neil Love

Research To Practice | Oncology VideosDr Neil Love

ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Dara S. Ross

MD; oncologist discussing ESR1 mutation-directed breast cancer management

Memorial Sloan Kettering Cancer Center

Episode: S17 Ep24: Evolving ESR1 Mutation Testing Directions Complicate the Future of Metastatic Breast Cancer Management: With Pedram Razavi, MD, PhD; and Dara S. Ross, MD

Pedram Razavi

MD, PhD; oncologist discussing ESR1 mutation-directed breast cancer management

Memorial Sloan Kettering Cancer Center

Episode: S17 Ep24: Evolving ESR1 Mutation Testing Directions Complicate the Future of Metastatic Breast Cancer Management: With Pedram Razavi, MD, PhD; and Dara S. Ross, MD

Peter Enzinger, MD

Medical oncologist

Episode: S17 Ep22: Answering Key Clinical Questions About Esophageal Cancer Care: With Peter Enzinger, MD

Michael Wang

Putin Clark Endowed Professor in the Department of Lymphoma and Myeloma, MD Anderson Cancer Center

MD Anderson Cancer Center

Episode: S17 Ep23: FDA Approval Insights: Brexu-Cel for Relapsed/Refractory MCL: With Luhua (Michael) Wang, MD

Annie Bond

Comedian, content creator, and 10-year metastatic breast cancer survivor

Independent creator

Episode: S17 Ep21: Honesty and Humor Provide Hope in Breast Cancer Survivorship: With Sara Nunnery, MD, MSCI; and Annie Bond

Michael J. Pishvaian, MD, PhD

Oncologist specializing in GI cancers, invited guest for expert discussion on biomarker-directed GI oncology

Episode: S17 Ep20: Biomarker-Directed Therapies Move the GI Oncology Paradigm Beyond a One-Size-Fits-All Approach: With Michael J. Pishvaian, MD, PhD

Alissa Cooper, MD

Physician guest discussing relapsed SCLC

Episode: S17 Ep14: Treatment Advances in Relapsed SCLC Introduce New Options and Clinical Workflows: With Alissa Cooper, MD

Kelly Elizabeth McCann

Oncologist discussing ctDNA applications and trial data

Academic/clinical breast cancer research

Episode: S17 Ep13: Cases and Conversations: Translating ctDNA Into Clinical Decisions in Breast Cancer

Wassim Mchayleh

Expert discussing ctDNA in surveillance and therapy decisions

Academic/clinical breast cancer research

Episode: S17 Ep13: Cases and Conversations: Translating ctDNA Into Clinical Decisions in Breast Cancer

Hosts

Riley Kandel

Host of OncLive On Air

Aisling Wehner

Host of OncLive On Air

Reviews

4.5 out of 5 stars from 32 ratings

Best option for CME podcasts
Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!
Apple Podcasts
5
Dlshaka
United Statesa year ago
My favorite podcast for oncology
This podcast provides excellent information to anyone who works in the medical field on oncology.
Apple Podcasts
5
Chiliman1986
United States6 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Highly relevant for CME and clinical practice updates.

Strong focus on trials and biomarkers; great for sponsor alignment with oncologic education.

Consistently practical and data-driven, though dense for casual listeners.

Clear, credible expert voices with in-depth clinical context.

Top Health & Fitness Podcasts

The Dylan Gemelli PodcastDylan Gemelli

Huberman LabScicomm Media

Passion Struck with John R. MilesPassion Struck with John R. Miles

The Dr. Josh Axe ShowDr. Josh Axe

On Purpose with Jay ShettyiHeartPodcasts

The Dr. John Delony ShowRamsey Network

We're Out of TimeRichard Taite

Nothing much happens: bedtime stories to help you sleepWellness Loud

The School of GreatnessLewis Howes

unPAUSED with Dr. Mary Claire HaverAudacy | Mary Claire Haver, MD

Talking Points

Recent interactions between the hosts and their guests.

S17 Ep26: Emerging Targets, Second-Line Standards, and Molecular Subtyping Signal a New Era in SCLC Care: With Jacob Sands, MD

Q: For the oncologists in the community, what is the most important takeaway from your recent work here?

Community oncologists should recognize the expanding trial landscape and the growing array of drugs in development for SCLC, with an emphasis on enrolling patients in biomarker-informed trials and considering local access to trials, including CAR-T and T-cell engager studies, to offer durable responses where traditional cytotoxics may be limited.

S17 Ep26: Emerging Targets, Second-Line Standards, and Molecular Subtyping Signal a New Era in SCLC Care: With Jacob Sands, MD

Q: What were the most compelling biomarker signals you observed here and how do you envision those findings shaping the design of future trials in the space?

Correlates in cell-free DNA and circulating tumor cells appeared with prognosis and progression, suggesting these biomarkers could be incorporated into trial designs for monitoring disease and potentially selecting patients; ongoing work aims to establish practical, clinically actionable uses of liquid biopsy in SCLC, particularly in MRD contexts and longitudinal monitoring.

S17 Ep26: Emerging Targets, Second-Line Standards, and Molecular Subtyping Signal a New Era in SCLC Care: With Jacob Sands, MD

Q: As a panel member here, what would you say are the most meaningful updates in version 2 of 2026 of the NCCN guidelines for small cell? And where does the panel see the most urgent gaps that's only to be addressed in future iterations of the guidelines?

The NCCN update removes the second-line split by chemotherapy-free interval and places Tarlatumab as the category one second-line option across the board, reflecting its trial-positive performance; also, there is increased emphasis on recognizing paraneoplastic syndromes like LEMS and referring for neurology management, signaling a more integrated care approach, while acknowledging gaps in biomarker-driven decisions and the need for further trials to refine subtyping-based strategies.

S17 Ep24: Evolving ESR1 Mutation Testing Directions Complicate the Future of Metastatic Breast Cancer Management: With Pedram Razavi, MD, PhD; and Dara S. Ross, MD

Q: Is there anything else you want to add about optimizing ESR1 testing workflows and staying on top of this practice going forward?

The clinicians emphasize a dual approach to testing, combining liquid biopsy and tissue sequencing to capture clonal and acquired mutations, while expanding the genomic panel to identify other actionable alterations that inform personalized therapy.

S17 Ep22: Answering Key Clinical Questions About Esophageal Cancer Care: With Peter Enzinger, MD

Q: What is the current role of surgery in esophageal cancer, and how do you decide which patients benefit most from surgery versus definitive chemoradiation or systemic therapy?

Surgery remains the most important curative option, with a shifting approach in squamous cell carcinoma toward fewer surgeries unless needed post-chemo-radiation, while adenocarcinoma often still requires chemotherapy; the trend is toward non-operative strategies when feasible, but surgery remains critical for candidates likely to achieve cure.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

A concise, clinician-focused show featuring in-depth conversations with academic oncologists and researchers about cutting-edge cancer care, trial results, and evolving treatment paradigms across thoracic, breast, GI, and gynecologic malignancies. Episodes emphasize biomarker-driven strategies, targeted therapies, and practical workflows for multidisciplinary teams, often discussing real-world implementation, patient impact, and access considerations. Noteworthy strengths include a strong emphasis on data interpretation, up-to-date trial context, and insights from leading cancer centers, making it especially valuable for oncology professionals seeking continuing education, clinical guidance, and context for emerging therapies. Potential lis... more

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Two Onc Docs
2. Oncology Brothers: Practice-Changing Cancer Discussions
3. Oncology Today with Dr Neil Love
4. Research To Practice | Oncology Videos
5. ASCO Daily News

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Dara S. Ross
2. Pedram Razavi
3. Peter Enzinger, MD
4. Michael Wang
5. Annie Bond
6. Michael J. Pishvaian, MD, PhD
7. Alissa Cooper, MD
8. Kelly Elizabeth McCann

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days